From €4404EUR$4,900USD£3,823GBP
- Report
- November 2025
- 186 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- September 2025
Global
From €4404EUR$4,900USD£3,823GBP
- Report
- January 2026
- 186 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Report
- March 2026
- 372 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- June 2025
- 400 Pages
Global
From €4448EUR$4,949USD£3,862GBP
- Report
- October 2025
- 160 Pages
Global
From €3018EUR$3,358USD£2,620GBP
€3551EUR$3,950USD£3,082GBP
- Report
- August 2025
- 150 Pages
United States
From €4359EUR$4,850USD£3,784GBP
- Report
- April 2019
- 153 Pages
Global
From €2472EUR$2,750USD£2,146GBP
- Report
- October 2023
- 140 Pages
North America
From €3595EUR$4,000USD£3,121GBP
- Report
- May 2024
- 213 Pages
Global
From €4490EUR$4,995USD£3,897GBP
- Report
- January 2025
- 270 Pages
Global
From €4490EUR$4,995USD£3,897GBP
- Report
- January 2026
- 150 Pages
Japan
From €4359EUR$4,850USD£3,784GBP
- Report
- January 2026
- 150 Pages
India
From €4359EUR$4,850USD£3,784GBP
- Report
- October 2025
- 150 Pages
Germany
From €4359EUR$4,850USD£3,784GBP
- Report
- September 2025
- 150 Pages
China
From €4359EUR$4,850USD£3,784GBP
- Report
- September 2025
- 150 Pages
Canada
From €4359EUR$4,850USD£3,784GBP

Nephropathy is a medical condition that affects the kidneys and is a major focus of Urology and Nephrology. It is caused by a variety of factors, including diabetes, hypertension, and glomerulonephritis. Symptoms of nephropathy can include proteinuria, edema, and hypertension. Treatment options vary depending on the cause and severity of the condition, but may include medications, lifestyle changes, and dialysis.
The nephropathy market is a rapidly growing sector of the Urology and Nephrology industry. It is driven by the increasing prevalence of chronic kidney diseases, as well as the development of new treatments and technologies. Companies in this market are focused on developing and marketing products and services to diagnose, treat, and manage nephropathy. Examples of companies in this market include Baxter International, Fresenius Medical Care, and DaVita. Show Less Read more